344
Views
21
CrossRef citations to date
0
Altmetric
Review

Primary Resistance Pattern of Helicobacter pylori to Antibiotics in Adult Population: A Systematic Review

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1567-1573 | Published online: 28 May 2020

References

  • CDC. Helicobacter Pylori. Fact Sheet for Health Care Providers. Department of Health and Human Services 1–4. 1998.
  • Blanchard TG, Nedrud JG. Laboratory maintenance of Helicobacter species. Curr Protoc Microbiol. 2012;24:8B.1.1-8B.1.19. doi:10.1002/9780471729259.mc08b01s24
  • Smith SM, O’morain C, Mcnamara D. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. World J Gastroenterol. 2014;20:9912. doi:10.3748/wjg.v20.i29.991225110421
  • Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808. doi:10.1111/j.1572-0241.2007.01393.x17608775
  • Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014;19:1–5. doi:10.1111/hel.12165
  • Fuccio L, Laterza L, Zagari RM, Cennamo V, Grilli D, Bazzoli F. Treatment of Helicobacter pylori infection. BMJ. 2008;15:337.
  • Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112:212–239. doi:10.1038/ajg.2016.56328071659
  • Malfertheiner P, Megraud F, O’morain CA, et al. Management of Helicobacter pylori infection, the Maastricht IV/Florence consensus report. Gut. 2012;61:646–664. doi:10.1136/gutjnl-2012-30208422491499
  • Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10:S122–S129. doi:10.1038/nm114515577930
  • Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol. 2008;5(6):321–331. doi:10.1038/ncpgasthep113818446147
  • Nishizawa T, Suzuki H. Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing. Front Mol Biosci. 2014;1. doi:10.3389/fmolb.2014.00019
  • Wu W, Yang Y, Sun G. Recent insights into antibiotic resistance in Helicobacter pylori eradication. Gastroenterol Res Pract. 2012;2012:1–8. doi:10.1155/2012/723183
  • De Francesco V, Giorgio F, Hassan C, et al. Worldwide H.pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis. 2010;19.
  • Lee JW, Kim N, Kim JM, et al. Prevalence of primary and secondary antimicrobial resistance of helicobacter pylori in Korea from 2003 through 2012. Helicobacter. 2013;18:206–214. doi:10.1111/hel.1203123241101
  • De Francesco V, Giorgio F, Ierardi E, et al. Primary clarithromycin resistance in Helicobacter pylori: the multicentric Italian clarithromycin resistance observational (MICRO) study. J Gastrointestin Liver Dis. 2011;20:235–239.21961089
  • Alzoubi K, Ayoub N, Al-Sakaji S, Al-Azzam S, Mhaidat N, Masadeh M. Awareness of bacterial resistance among physicians, pharmacists and nurses. Int J Occup Med Environ Health. 2009;22:363–372. doi:10.2478/v10001-009-0034-320197263
  • Owen R. Molecular testing for antibiotic resistance in Helicobacter pylori. Gut. 2002;50:285–289. doi:10.1136/gut.50.3.28511839700
  • Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 10.1371/journal.pmed.1000097.
  • Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67:974–978. doi:10.1136/jech-2013-20310423963506
  • Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed 54, 2020.
  • Zhang YX, Zhou LY, Song ZQ, Zhang JZ, He LH, Ding Y. Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study. World J Gastroenterol. 2015;21:2786. doi:10.3748/wjg.v21.i9.278625759550
  • Agudo S, Pérez-Pérez G, Alarcón T, López-Brea M. High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain. J Clin Microbiol. 2010;48:3703–3707. doi:10.1128/JCM.00144-1020668128
  • Rispo A, Capone P, Castiglione F, Pasquale L, Rea M, Caporaso N. Fluoroquinolone-based protocols for eradication of Helicobacter pylori. World J Gastroenterol. 2014;20.
  • Caliskan R, Tokman HB, Erzin Y, et al. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. Rev Soc Bras Med Trop. 2015;48:278–284. doi:10.1590/0037-8682-0027-201526108005
  • Ferenc S, Gnus J, Kościelna M, et al. High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland. Helicobacter. 2017;22:e12365. doi:10.1111/hel.12365
  • Ang TL, Fock KM, Ang D, Kwek ABE, Teo EK, Dhamodaran S. The changing profile of Helicobacter pylori antibiotic resistance in Singapore: a 15 year study. Helicobacter. 2016;21:261–265. doi:10.1111/hel.1229126774006
  • Boehnke KF, Valdivieso M, Bussalleu A, et al. Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru. Infect Drug Resist. 2017;10:85–90. doi:10.2147/IDR.S12379828331349
  • Tamayo E, Montes M, Fernández-Reyes M, et al. Clarithromycin resistance in Helicobacter pylori and its molecular determinants in Northern Spain, 2013–2015. J Glob Antimicrob Resist. 2017;9:43–46. doi:10.1016/j.jgar.2016.12.01928343971
  • Shiota S, Reddy R, Alsarraj A, El-Serag HB, Graham DY. Antibiotic resistance of Helicobacter pylori among male United States veterans. Clin Gastroenterol Hepatol. 2015;13:1616–1624. doi:10.1016/j.cgh.2015.02.00525681693
  • Eng NF, Ybazeta G, Chapman K, et al. Antimicrobial susceptibility of Canadian isolates of Helicobacter pylori in Northeastern Ontario. Can J Infect Dis Med Microbiol. 2015;26:137–144. doi:10.1155/2015/85328726236355
  • Sanches BS, Martins GM, Lima K, et al. Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: a national survey. World J Gastroenterol. 2016;22:7587. doi:10.3748/wjg.v22.i33.758727672279
  • Miftahussurur M, Shrestha PK, Subsomwong P, Sharma RP, Yamaoka Y. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. BMC Microbiol. 2016;16:256. doi:10.1186/s12866-016-0873-627809767
  • Liou JM, Chang CY, Chen MJ, et al. The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors—a nationwide study. PLoS One. 2015;10:e0124199. doi:10.1371/journal.pone.012419925942450
  • Bouihat N, Burucoa C, Benkirane A, et al. Helicobacter pylori primary antibiotic resistance in 2015 in morocco: a phenotypic and genotypic prospective and multicenter study. Microb Drug Resist. 2016.
  • Zaki MES, Sherif DM, Ali MA, et al. molecular study of primary clarithromycin resistant Helicobacter pylori strains from Egyptian Centre. Int J Curr Microbiol App Sci. 2016;5:165–173. doi:10.20546/ijcmas.2016.501.014
  • Harrison U, Fowora MA, Seriki AT, et al. Helicobacter pylori strains from a Nigerian cohort show divergent antibiotic resistance rates and a uniform pathogenicity profile. PLoS One. 2017;12:e0176454. doi:10.1371/journal.pone.017645428463973
  • Ghotaslou R, Leylabadlo HE, Asl YM. Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review. World J Methodol. 2015;5:164. doi:10.5662/wjm.v5.i3.16426413490
  • Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:1197–1202. doi:10.1093/cid/ciw21727118828
  • Khademi F, Poursina F, Hosseini E, Akbari M, Safaei HG. Helicobacter pylori in Iran: A systematic review on the antibiotic resistance. Iran J Basic Med Sci. 2015;18.
  • Kocazeybek B, Tokman HB. Prevalence of primary antimicrobial resistance of H. pylori in Turkey: a systematic review. Helicobacter. 2016;21:251–260. doi:10.1111/hel.1227226395982
  • Camargo MC, García A, Riquelme A, et al. The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America. Am J Gastroenterol. 2014;109:485–495. doi:10.1038/ajg.2014.2424589670
  • Hu Y, Zhu Y, Lu NH. Primary antibiotic resistance of helicobacter pylori in China. Dig Dis Sci. 2017;1–9.27853897
  • Malfertheiner P, Megraud F, O’morain C, et al. Management of Helicobacter pylori infection, the Maastricht V/Florence consensus report. Gut. 2016;1–25.
  • Acar JF. Consequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis. 1997;24:17–18. doi:10.1093/clinids/24.Supplement_1.S178994749
  • Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22:416–422. doi:10.1016/j.cmi.2015.12.00226706614
  • Miftahussurur M, Waskito LA, Syam AF, et al. Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance. Infect Drug Resist. 2019;12:345. doi:10.2147/IDR.S18706330774400
  • Olleik H, Baydoun E, Perrier J, et al. Temporin-SHa and its analogs as potential candidates for the treatment of helicobacter pylori. Biomolecules. 2019;9:598. doi:10.3390/biom9100598
  • Shmuely H, Domniz N, Yahav J. Regional antibiotic resistance of helicobacter pylori. JSM Gastroenterol Hepatol. 2016;4:1074.
  • Seck A, Burucoa C, Dia D, et al. Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients. Ann Clin Microbiol Antimicrob. 2013;12:3. doi:10.1186/1476-0711-12-323298145